Christopher R Reid

US Patent:

8191017, May 29, 2012

Filed:

Jan 14, 2009

Appl. No.:

12/353834

Inventors:

George P. Lipincott - Lake Oswego OR, US
Christopher E. Reid - Tigard OR, US

Assignee:

Mentor Graphics Corp. - Wilsonville OR

International Classification:

G06F 17/50

US Classification:

716 53, 716 52, 430 5

Abstract:

Techniques for performing optical proximity correction on a layout design or portion thereof are provided with various implementations of the invention. With various implementations of the invention, movement and simulation of selected edge fragments is disabled during the optical proximity correction process. The operations of the optical proximity correction process, such as for example simulation and displacement of edge segments, is then performed for the edge fragments that remain enabled. With further implementations of the invention, a simulation site is defined for ones of the edge fragments. The operations of the optical proximity correction process, such as for example simulation and displacement of edge segments, is performed for each simulation site. Additionally, during the optical proximity correction process, the simulations sites may be moved and or removed individually based on various conditions.

US Patent:

8352891, Jan 8, 2013

Filed:

Aug 19, 2010

Appl. No.:

12/859743

Inventors:

Christopher E Reid - Tigard OR, US
George P Lippincott - Lake Oswego OR, US
Sergiy M Komirenko - Cupertino CA, US

Assignee:

Mentor Graphics Corporation - Wilsonville OR

International Classification:

G06F 17/50
G06F 19/00
G03F 1/00
G21K 5/00

US Classification:

716 55, 716 52, 716 53, 716 54, 716106, 716111, 700 98, 700121, 430 5, 378 35

Abstract:

Layout design data are decomposed for double dipole lithography based on partial intensity distribution information. The partial intensity distribution information is generated by performing optical simulations on the layout design data. The layout decomposition may further be adjusted during an optical proximity correction process. The adjustment may utilize the partial intensity distribution information.

US Patent:

8533637, Sep 10, 2013

Filed:

Dec 29, 2010

Appl. No.:

12/981340

Inventors:

Christopher E Reid - Tigard OR, US
George P Lippincott - Lake Oswego OR, US

Assignee:

Mentor Graphics Corporation - Wilsonville OR

International Classification:

G06F 17/50

US Classification:

716 53, 716 50, 716 51, 716 54, 716 55

Abstract:

Aspects of the invention relate to retargeting based on process window simulation to fix hotspots. The process window simulation is performed to generate process window information. Edge fragments are selected for retargeting. Based on the process window information, the selected edge fragments are retargeted in a balanced way.

US Patent:

20080206202, Aug 28, 2008

Filed:

Oct 29, 2007

Appl. No.:

11/927399

Inventors:

Christopher Reid - Long Beach CA, US
Svetlana Pack - Gaithersburg MD, US

International Classification:

A61K 48/00
C12N 5/06

US Classification:

424 936, 435377, 424 937

Abstract:

We propose here that endogenous stem/progenitor cells of the developing or adult nervous system be genetically modified in situ, to express therapeutically advantageous gene products. Furthermore, we propose here that endogenous or other exogenous stem cells or their progeny be genetically modified when appropriate to express advantageous gene products (and/or modified through culture techniques), and that, if exogenously derived, they be transplanted into the ventricular system of the patient nervous system, the germinal zone of the ventricular system, into postmitotic regions of the CNS or other organs.

US Patent:

20210378639, Dec 9, 2021

Filed:

Jun 4, 2021

Appl. No.:

17/338736

Inventors:

T. Que COLLINS - Los Angeles CA, US
Christopher Brian REID - Los Angeles CA, US

International Classification:

A61B 10/00
G01N 33/543

Abstract:

An exhaled breath condensate (EBC) collection device comprising two adjacent parts foldable together and apart from each other, a condensation zone to condense exhaled breath from a subject, the condensation zone being a third part provided between the two adjacent parts and connectable to cooling means arranged in each of the two parts being in cooling relationship with the condensation zone. There is also provided a method for detecting antigens or antibodies to the antigens, the method comprising collecting EBC from a subject using the EBC collection device, performing immunochromatographic testing (ICT) of the collected exhaled breath condensate, and interpreting the immunochromatographic testing results as follows: if the immunochromatographic testing results are positive, the antigens or antibodies to the antigens are detected, or if the immunochromatographic testing results are negative, the antigens or antibodies to the antigens are not detected.

US Patent:

20200048600, Feb 13, 2020

Filed:

Sep 24, 2019

Appl. No.:

16/579889

Inventors:

Christopher B. REID - Los Angeles CA, US
Melissa BRAGA - Monterey Park CA, US
Lilian N. SANTAMARIA - Los Angeles CA, US
Ashley N. WICKREMA - Los Angeles CA, US
Marinne D. WICKREMA - Los Angeles CA, US
Anthony HAO DINH - Garden Grove CA, US
Yaman EKSIOGLU - Atlanta GA, US
Mat HOANG HO - Birmingham AL, US

International Classification:

C12M 1/00
C12N 15/10
C12N 15/11
C12M 3/00
C12M 1/42

Abstract:

The claimed invention is directed towards a novel combination cell electroporation/cell culturing apparatus which can be termed a cell culture dish suitable for in vitro electroporation, and towards a device suitable for in vivo electroporation—both useful in methods suitable for the generation of developmentally-activated, pluripotent, pluripotent-like, multipotent, and/or self-renewing cells which are capable of beginning to differentiate in culture into a variety of cell types and capable of further differentiation in vivo. The claimed invention is also directed towards the generation of desirable, differentiating somatic cell populations transplantable to animals or patients, genetic modification of endogenous and exogenous cells, and the treatment of patients suffering from diseases that may be ameliorated by these methods. This invention also provides methods for preventing, treating, or retarding disease, for example, immunodeficiency virus (e.g. HIV-1, HIV-2, SIV, FIV, etc.) infection.

US Patent:

20190256813, Aug 22, 2019

Filed:

Oct 26, 2018

Appl. No.:

16/171420

Inventors:

Christopher B. REID - Los Angeles CA, US

International Classification:

C12M 3/06
C12M 1/00
C12N 5/00
C12M 1/42
C12N 13/00

Abstract:

A cell culture dish made of non media-permeable material and having a base and a plurality of separate juxtaposed side-by-side wells having common interior well walls preventing physical contact or movement of chemical factors between the separated cell or tissue cultures, the walls having different heights and defining an outer “surround” cell or tissue culture and one or more inner “center” cell or tissue cultures to enable contained cell or tissue communication between the well spaces, the wells configured to comprise two or more cell or tissue cultures, the wells permitting signal communication between the cells or tissues situated within said wells, and further comprising wall material, electrode contacts electrodes and/or electrode contacts, and well dimensions suitable for facilitating electroporation. The inventor observed 100% efficiency in cell reprogramming with protein electroporation-orders of magnitude above other reported methods.

US Patent:

20190008853, Jan 10, 2019

Filed:

Jul 18, 2018

Appl. No.:

16/039134

Inventors:

Christopher Brian REID - Los Angeles CA, US

International Classification:

A61K 31/496
A61K 45/06
A61K 31/327
A61K 31/4164
A61K 31/375
A61K 31/355
A61K 31/12
A61K 31/122
A61K 38/06
A61K 31/194
A61K 38/18
A61K 36/00

Abstract:

A method for reducing motility and number of cells, said method comprising contacting the cells with an effective amount of a composition, the composition comprising a combination of metronidazole and itraconazole, wherein the effective amount is sufficient to reduce motility of the cells.